PDI Stock Rating Upgraded by Zacks (PDII)
PDI (NASDAQ:PDII) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Wednesday, StockRatingsNetwork reports. The firm currently has a $6.30 price target on the stock. Zacks‘ price target suggests a potential upside of 9.95% from the company’s current price.
PDI (NASDAQ:PDII) traded up 2.44% during mid-day trading on Wednesday, hitting $5.87. 10,952 shares of the company’s stock traded hands. PDI has a 52 week low of $3.82 and a 52 week high of $7.88. The stock’s 50-day moving average is $5.07 and its 200-day moving average is $4.8. The company’s market cap is $89.0 million.
PDI (NASDAQ:PDII) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.09. On average, analysts predict that PDI will post $-0.17 earnings per share for the current fiscal year.
PDI, Inc provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.